Lynparza
NDC 0310-0569, olaparib, tablet, film coated, from AstraZeneca Pharmaceuticals LP.
- Product NDC
- 0310-0569
- Status
- Listed
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208558
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OLAPARIB100 mg/1
Pharmacologic classes
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0310-0569-12 | 00310056912 | 120 TABLET, FILM COATED in 1 BOTTLE (0310-0569-12) |
| 0310-0569-60 | 00310056960 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0310-0569-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/741ff3e3-dc1a-45a6-84e5-2481b27131aa
Use it
Look up 0310-0569 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0310-0569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.